证券日报网讯 8月21日晚间，金麒麟发布公告称，公司于2025年8月21日召开第五届董事会2025年第三 次会议，审议通过了《山东金麒麟股份有限公司关于聘任高级管理人员的议案》，同意聘任张建勇先生 为公司副总经理，任期从就任之日起计算，至本届董事会任期届满时为止。 （编辑 李家琪） ...

Buyback and Shareholder Actions - Sinopec plans to repurchase A-shares with a total fund of no less than RMB 5 billion and no more than RMB 10 billion, potentially reducing its registered capital [1] - Hengbang Mining intends to reduce its stake in the Hong Kong-listed company, WanGuo Gold, by up to 40 million shares, representing approximately 3.69% of WanGuo's total share capital [5] Product Approvals and Market Launches - Wantai Biological's nine-valent HPV vaccine has received the batch release certificate, marking its official market launch and enhancing the company's product lineup [1] - Changchun High-tech's subsidiary has received acceptance for the clinical trial application of GenSci143, a dual-specific antibody drug, which may provide new treatment options for certain tumors [7] Financial Performance - Hongxin Electronics reported a 15.01% increase in revenue to RMB 3.494 billion and a 9.85% rise in net profit to RMB 53.99 million for the first half of 2025 [2] - Sanwei Xinan experienced a net loss of RMB 29.39 million in the first half of 2025, despite a 15.19% increase in revenue to RMB 195 million [3] Corporate Developments - TianTan Bio received a commitment from its controlling shareholder to resolve new competition issues arising from a recent acquisition [4] - Feilu Co. announced a potential change in control, leading to a temporary suspension of its stock trading [8] Investment and Expansion - Jinbei Electric's subsidiary has signed a purchase agreement for a factory in Europe, marking significant progress in establishing its European production base [1] - Shengshi Technology plans to establish a wholly-owned subsidiary to integrate AI and humanoid robot technology with innovative toy products, investing RMB 10 million [6]

证券日报网讯 8月21日晚间，金麒麟发布公告称，公司第五届监事会2025年第三次会议审议通过了《山 东金麒麟股份有限公司2025年半年度报告全文及摘要》等多项议案。 （文章来源：证券日报） ...

Core Insights - The company reported a revenue of 964 million yuan for the first half of 2025, representing a year-on-year growth of 24.34% [1] - The net profit attributable to shareholders reached 108 million yuan, showing a significant year-on-year increase of 226.14% [1] - The net profit attributable to shareholders after deducting non-recurring gains and losses was 106 million yuan, reflecting a year-on-year growth of 212.92% [1] - The basic earnings per share stood at 0.55 yuan [1]

（文章来源：每日经济新闻） 金麒麟（SH 603586，收盘价：22.16元）8月21日晚间发布半年度业绩报告称，2025年上半年营业收入 约9.64亿元，同比增加24.34%；归属于上市公司股东的净利润约1.08亿元，同比增加226.14%；基本每 股收益0.55元，同比增加223.53%。 ...

金麒麟（SH 603586，收盘价：22.16元）8月21日晚间发布公告称，经董事会提名委员会审查，审议通 过了《山东金麒麟股份有限公司关于聘任高级管理人员的议案》，同意聘任张建勇先生为公司副总经 理，任期从就任之日起计算，至本届董事会任期届满时为止。 2024年1至12月份，金麒麟的营业收入构成为：汽车零部件及配件制造行业占比98.32%，其他业务占比 1.68%。 （文章来源：每日经济新闻） ...

（文章来源：每日经济新闻） 金麒麟（SH 603586，收盘价：22.16元）8月21日晚间发布公告称，公司第五届2025年第三次董事会会 议于2025年8月21日在公司董事会会议室以现场结合通讯方式召开。会议审议了《山东金麒麟股份有限 公司2025年半年度报告全文及摘要》等文件。 2024年1至12月份，金麒麟的营业收入构成为：汽车零部件及配件制造行业占比98.32%，其他业务占比 1.68%。 ...

Suspension - Feilu Co., Ltd. is planning a change in company control, leading to the suspension of its stock [1] Capital Increase and Mergers - Yunnan Copper Industry has submitted an application to acquire 40% of Liangshan Mining, which has been accepted by the Shenzhen Stock Exchange [2] - Zhenghe Industrial plans to raise no more than 818 million yuan through a private placement for agricultural machinery component expansion, garden tool chain saw system project, micro chain system software and hardware integration R&D, and to supplement working capital [2] - iFlytek intends to raise no more than 4 billion yuan through a private placement for the Spark Education large model and typical products, and to supplement working capital; a shareholder, Yanzhi Technology, plans to subscribe for no less than 250 million yuan and no more than 350 million yuan [2] External Investment and Daily Operations - Wantai Biological Pharmacy's nine-valent human papillomavirus vaccine has received its first batch release certificate [3] - Hanyu Pharmaceutical's acetic acid atoziban injection has obtained marketing approval in Vietnam [4] - Zai Jian Pharmaceutical has received clinical trial approval for injectable ZG005, injectable ZGGS18, and the combination with hydrochloride gikaixin tablets [5] - Changchun High-tech's subsidiary has had its clinical trial application for injectable GenSci143 accepted [6] - Jinbo Co., Ltd. has received a notification from a leading OEM, selecting the company as a designated supplier for developing and supplying carbon-ceramic brake disc products [6] - Greeenmei has signed a strategic cooperation agreement with Weilan Lithium Core to create a high-energy battery materials and solid-state battery innovation consortium [7] - Anyuan Coal Industry plans to change its stock name to "Jiang Tung Equipment" [8] Performance Changes - Qianfang Technology reported a net profit of 170 million yuan in the first half of the year, a year-on-year increase of 1287.12% [9] - Sainuo Medical's net profit in the first half of the year increased by 296.54% year-on-year [10] - Jin Qilin reported a net profit of 108 million yuan in the first half of the year, a year-on-year increase of 226.14% [11] - Qianzhao Optoelectronics reported a net profit of 69.23 million yuan in the first half of the year, a year-on-year increase of 88.04% [12] - Miaokelando reported a net profit of 133 million yuan in the first half of the year, a year-on-year increase of 86.27% [12] - Hudian Co., Ltd. reported a net profit of 1.683 billion yuan in the first half of the year, a year-on-year increase of 48% [12] - GoerTek reported a net profit of 1.417 billion yuan in the first half of the year, a year-on-year increase of 15.65% [12] - Yunnan Ge Industry reported a net profit of 22.15 million yuan in the first half of the year, returning to profitability [12]

本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 会 议 问 题 征 集 ： 投 资 者 可 于 2025 年 8 月 29 日 前 访 问 网 址 https://eseb.cn/1qTymeYX8di 或使用微信扫描下方小程序码进行会前提问，公司 将通过本次业绩说明会，在信息披露允许范围内就投资者普遍关注的问题进行回 答。 证券代码：603586 证券简称：金麒麟 公告编号：2025-031 山东金麒麟股份有限公司 关于召开 2025 年半年度业绩说明会的公告 一、说明会类型 山东金麒麟股份有限公司（以下简称"公司"）于 2025 年 8 月 22 日在上海证 券交易所网站（www.sse.com.cn）披露《山东金麒麟股份有限公司 2025 年半年 度报告》《山东金麒麟股份有限公司 2025 年半年度报告摘要》。为便于广大投 资者更加全面深入地了解公司经营业绩、发展战略等情况，公司定于 2025 年 8 月 29 日（星期五）15:00-16:00 在"价值在线"（www.ir-online.cn）举办山东 ...

证券代码：603586 证券简称：金麒麟 公告编号：2025-029 山东金麒麟股份有限公司 关于聘任高级管理人员的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 根据《中华人民共和国公司法》(以下简称"《公司法》")和《山东金麒麟 股份有限公司章程》(以下简称"《公司章程》")等有关规定，经董事会提名委 员会审查，山东金麒麟股份有限公司(以下简称"公司")于 2025 年 8 月 21 日召 开第五届董事会 2025 年第三次会议，审议通过了《山东金麒麟股份有限公司关 于聘任高级管理人员的议案》，同意聘任张建勇先生为公司副总经理，任期从就 任之日起计算，至本届董事会任期届满时为止。 提名委员会审查意见：提名委员会对张建勇先生的任职资格和标准进行了审 查，认为其具备有关法律法规规定的任职资格，不存在《公司法》和《公司章程》 中规定的不得担任公司副总经理的情形，以及被中国证监会确定为市场禁入者或 者禁入尚未解除的情况。任职资格和聘任程序符合《公司法》《上海证券交易所 股票上市规则》和《公司章程》等有关规定。 张建勇先 ...